NEW YORK, April 15, 2014 /PRNewswire/ -- Repligen
Corporation (NASD:RGEN) will replace Hi-Tech Pharmacal Co., Inc.
(NASD:HITK) in the S&P SmallCap 600 after the close of trading
on Thursday, April 17. S&P
SmallCap 600 constituent Akorn Inc. (NASD:AKRX) is acquiring
Hi-Tech Pharmacal Co. in a deal expected to be completed soon.
Repligen Corporation is a life sciences company focused on the
development, production and commercialization of high-value
consumable products used in the process of manufacturing biological
drugs. Headquartered in Waltham,
MA, the company will be added to the S&P SmallCap 600
GICS (Global Industry Classification Standard) Biotechnology
Sub-Industry index.
Following is a summary of the change:
S&P SMALLCAP
600 INDEX – April 17, 2014
|
|
COMPANY
|
GICS ECONOMIC
SECTOR
|
GICS
SUB-INDUSTRY
|
ADDED
|
Repligen
|
Health
Care
|
Biotechnology
|
DELETED
|
Hi-Tech
Pharmacal
|
Health
Care
|
Pharmaceuticals
|
Additions to and deletions from S&P Dow Jones Indices
do not in any way reflect an opinion on the investment merits of
the companies involved.
About S&P Dow Jones Indices
S&P Dow Jones Indices LLC, a part of McGraw Hill Financial,
is the world's largest, global resource for index-based concepts,
data and research. Home to iconic financial market indicators, such
as the S&P 500® and the Dow Jones Industrial Average™, S&P
Dow Jones Indices LLC has over 115 years of experience constructing
innovative and transparent solutions that fulfill the needs of
investors. More assets are invested in products based upon our
indices than any other provider in the world. With over 830,000
indices covering a wide range of asset classes across the globe,
S&P Dow Jones Indices LLC
defines the way investors measure and trade the markets. To
learn more about our company, please visit
www.spdji.com.
Standard & Poor's and S&P are registered trademarks
of Standard & Poor's Financial Services LLC, a part of McGraw
Hill Financial. Dow Jones is a registered trademark of Dow Jones
Trademark Holdings LLC ("Dow Jones"). These trademarks have
been licensed to S&P Dow Jones Indices LLC. It is not possible
to invest directly in an index. S&P Dow Jones Indices LLC, Dow
Jones, S&P and their respective affiliates (collectively
"S&P Dow Jones Indices") do not sponsor, endorse, sell, or
promote any investment fund or other investment vehicle that is
offered by third parties and that seeks to provide an investment
return based on the performance of any index. This document does
not constitute an offer of services in jurisdictions where S&P
Dow Jones Indices does not have the necessary licenses. S&P Dow
Jones Indices receives compensation in connection with licensing
its indices to third parties.
SOURCE S&P Dow Jones Indices LLC